Published :
Tables : 52
Figures : 47
Category : Healthcare
No. of Pages : 233
Report Code : HC-U3187
Osteoarthritis Therapeutics Market is poised to value USD 13262 million by 2028 end at a CAGR of 8.8% during the forecast period 2022 to 2028. Osteoarthritis is a chronic health condition that causes chronic pain and disability with reduced mobility. Degenerative arthritis in joints occurs when cartilage in one or more joints breaks down and eventually loses its integrity. The cartilage of joints between bones, such as those in the knees, ankles, and elbows, provides support and flexibility. Providing lubrication and reducing friction in the joint are its main benefits. As part of osteoarthritis treatment, the goal is to enhance both functional abilities and alleviate pain. In addition to the increase in osteoarthritis prevalence, advancements in research and development for drug development, increasing funding from private and government organizations to develop healthcare centers and research centers, and an increase in cell-based research activities are major factors contributing to the growth of the osteoarthritis therapeutics market. An article was published in Stem Cell International describing a new approach for treating osteoarthritis with mesenchyme stem cells. A rise in the number of drugs approved for prescription will drive the growth of the infectious disease diagnostic market. As well, a growing geriatric population fuels the growth in osteoarthritis therapeutics, owing to the fact that older people are more likely to develop the disease. In the treatment of OA, NSAIDs are the most effective oral medications. The most common of these are ibuprofen (Motrin, Advil), naproxen (Aleve) and diclofenac (Voltaren, among others). In all cases, these medications block enzymes that cause pain and swelling. Unfortunately, some of these enzymes also keep blood clots from forming and protect stomach linings from damage. FutureWise Market Research has instantiated a report that provides an intricate analysis of Osteoarthritis Therapeutics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Osteoarthritis Therapeutics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Osteoarthritis Therapeutics Market: Sanofi Horizon Therapeutics PLC Johnson & Johnson Glaxosmithkline PLC Bayer AG Abbott Pfizer, Inc. Eli Lilly Anika Therapeutics, Inc. Novartis Ferring Pharmaceuticals Bioventus Zimmer Biomet Holdings, Inc. Fidia Farmaceutici S.P.A. Flexion Therapeutics, Inc. (Note: The list of the major players will be updated with the latest market scenario and trends) Osteoarthritis Therapeutics Market Segmentation: By Anatomy Knee Hip Hand Small Joints (Foot & Ankle and Wrist) By Drug Type • Viscosupplementation Agents • Nonsteroidal Anti-inflammatory Drugs o Naproxen o Aspirin o Diclofenac o Ibuprofen o Other NSAIDs • Analgesics o Duloxetine o Acetaminophen • Corticosteroids By Route of Administration Parenteral Topical Oral By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies By Purchasing Pattern Prescription Drug Over-the-counter Drug By Region North America Europe Asia-Pacific Latin America Middle East and Africa Osteoarthritis Therapeutics Market Sample Video: Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the Osteoarthritis Therapeutics Market By Anatomy, By Drug Type, By Route of Administration, By Distribution Channel, By Purchasing Pattern and By Region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Osteoarthritis is a chronic health condition that causes chronic pain and disability with reduced mobility. Degenerative arthritis in joints occurs when cartilage in one or more joints breaks down and eventually loses its integrity. The cartilage of joints between bones, such as those in the knees, ankles, and elbows, provides support and flexibility. Providing lubrication and reducing friction in the joint are its main benefits. As part of osteoarthritis treatment, the goal is to enhance both functional abilities and alleviate pain. In addition to the increase in osteoarthritis prevalence, advancements in research and development for drug development, increasing funding from private and government organizations to develop healthcare centers and research centers, and an increase in cell-based research activities are major factors contributing to the growth of the osteoarthritis therapeutics market. An article was published in Stem Cell International describing a new approach for treating osteoarthritis with mesenchyme stem cells. A rise in the number of drugs approved for prescription will drive the growth of the infectious disease diagnostic market. As well, a growing geriatric population fuels the growth in osteoarthritis therapeutics, owing to the fact that older people are more likely to develop the disease. In the treatment of OA, NSAIDs are the most effective oral medications. The most common of these are ibuprofen (Motrin, Advil), naproxen (Aleve) and diclofenac (Voltaren, among others). In all cases, these medications block enzymes that cause pain and swelling. Unfortunately, some of these enzymes also keep blood clots from forming and protect stomach linings from damage.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Osteoarthritis Therapeutics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Osteoarthritis Therapeutics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Osteoarthritis Therapeutics Market:
(Note: The list of the major players will be updated with the latest market scenario and trends)
Osteoarthritis Therapeutics Market Segmentation:
By Anatomy
By Drug Type
• Viscosupplementation Agents • Nonsteroidal Anti-inflammatory Drugs o Naproxen o Aspirin o Diclofenac o Ibuprofen o Other NSAIDs • Analgesics o Duloxetine o Acetaminophen • Corticosteroids
By Route of Administration
By Distribution Channel
By Purchasing Pattern
By Region
Osteoarthritis Therapeutics Market Sample Video:
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Osteoarthritis Therapeutics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Osteoarthritis Therapeutics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Osteoarthritis Therapeutics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Osteoarthritis Therapeutics Market, By Anatomy Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Knee 7.2. Hip 7.3. Hand 7.4. Small Joints (Foot & Ankle and Wrist) 8. Osteoarthritis Therapeutics Market, By Drug Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Viscosupplementation Agents 8.2. Nonsteroidal Anti-inflammatory Drugs 8.2.1. Naproxen 8.2.2. Aspirin 8.2.3. Diclofenac 8.2.4. Ibuprofen 8.2.5. Other NSAIDs 8.3. Analgesics 8.3.1. Duloxetine 8.3.2. Acetaminophen 8.4. Corticosteroids 9. Osteoarthritis Therapeutics Market, By Route of Administration Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Parenteral 9.2. Topical 9.3. Oral 10. Osteoarthritis Therapeutics Market, By Distribution Channel Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospital Pharmacies 10.2. Retail Pharmacies 10.3. Online Pharmacies 11. Osteoarthritis Therapeutics Market, By Purchasing Pattern Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Prescription Drug 11.2. Over-the-counter Drug 12. North America Osteoarthritis Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028 13. Latin America Osteoarthritis Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028 14. Europe Osteoarthritis Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028 15. Asia Pacific Osteoarthritis Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Sanofi 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Horizon Therapeutics PLC 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Johnson & Johnson 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Glaxosmithkline PLC 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Bayer AG 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Abbott 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Pfizer, Inc. 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Eli Lilly 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Anika Therapeutics, Inc. 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Novartis 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11.Ferring Pharmaceuticals 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12.Bioventus 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13.Zimmer Biomet Holdings, Inc. 18.13.1. Company Overview 18.13.2. Product Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview 18.14.Fidia Farmaceutici S.P.A. 18.14.1. Company Overview 18.14.2. Product Portfolio 18.14.3. SWOT Analysis 18.14.4. Financial Overview 18.14.5. Strategic Overview 18.15.Flexion Therapeutics, Inc. 18.15.1. Company Overview 18.15.2. Product Portfolio 18.15.3. SWOT Analysis 18.15.4. Financial Overview 18.15.5. Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Osteoarthritis Therapeutics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Osteoarthritis Therapeutics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Osteoarthritis Therapeutics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Osteoarthritis Therapeutics Market, By Anatomy Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Knee 7.2. Hip 7.3. Hand 7.4. Small Joints (Foot & Ankle and Wrist)
8. Osteoarthritis Therapeutics Market, By Drug Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Viscosupplementation Agents 8.2. Nonsteroidal Anti-inflammatory Drugs 8.2.1. Naproxen 8.2.2. Aspirin 8.2.3. Diclofenac 8.2.4. Ibuprofen 8.2.5. Other NSAIDs 8.3. Analgesics 8.3.1. Duloxetine 8.3.2. Acetaminophen 8.4. Corticosteroids
9. Osteoarthritis Therapeutics Market, By Route of Administration Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Parenteral 9.2. Topical 9.3. Oral
10. Osteoarthritis Therapeutics Market, By Distribution Channel Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospital Pharmacies 10.2. Retail Pharmacies 10.3. Online Pharmacies
11. Osteoarthritis Therapeutics Market, By Purchasing Pattern Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Prescription Drug 11.2. Over-the-counter Drug
12. North America Osteoarthritis Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028
13. Latin America Osteoarthritis Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028
14. Europe Osteoarthritis Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028
15. Asia Pacific Osteoarthritis Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028
17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix
18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Sanofi 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Horizon Therapeutics PLC 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Johnson & Johnson 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Glaxosmithkline PLC 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Bayer AG 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Abbott 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Pfizer, Inc. 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Eli Lilly 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Anika Therapeutics, Inc. 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Novartis 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11.Ferring Pharmaceuticals 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12.Bioventus 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13.Zimmer Biomet Holdings, Inc. 18.13.1. Company Overview 18.13.2. Product Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview 18.14.Fidia Farmaceutici S.P.A. 18.14.1. Company Overview 18.14.2. Product Portfolio 18.14.3. SWOT Analysis 18.14.4. Financial Overview 18.14.5. Strategic Overview 18.15.Flexion Therapeutics, Inc. 18.15.1. Company Overview 18.15.2. Product Portfolio 18.15.3. SWOT Analysis 18.15.4. Financial Overview 18.15.5. Strategic Overview
19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations
20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics